Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cefzil 250mg/5ml oral suspension
0501020AABBACAC
|
Cefzil | Cefprozil | Infections | No data available |
|
Cefzil 500mg tablets
0501020AABBABAB
|
Cefzil | Cefprozil | Infections | No data available |
|
Celsentri 150mg tablets
0503010ADBBAAAA
|
Celsentri | Maraviroc | Infections | No data available |
|
Celsentri 20mg/ml oral solution
0503010ADBBACAC
|
Celsentri | Maraviroc | Infections | No data available |
|
Celsentri 25mg tablets
0503010ADBBAEAE
|
Celsentri | Maraviroc | Infections | No data available |
|
Celsentri 300mg tablets
0503010ADBBABAB
|
Celsentri | Maraviroc | Infections | No data available |
|
Celsentri 75mg tablets
0503010ADBBADAD
|
Celsentri | Maraviroc | Infections | No data available |
|
Ceporex 125mg/5ml syrup
0501021L0BBAHAC
|
Ceporex | Cefalexin | Infections | No data available |
|
Ceporex 250mg capsules
0501021L0BBAAAA
|
Ceporex | Cefalexin | Infections | No data available |
|
Ceporex 250mg tablets
0501021L0BBACAG
|
Ceporex | Cefalexin | Infections | No data available |
|
Ceporex 250mg/5ml syrup
0501021L0BBAIAD
|
Ceporex | Cefalexin | Infections | No data available |
|
Ceporex 500mg capsules
0501021L0BBABAB
|
Ceporex | Cefalexin | Infections | No data available |
|
Ceporex 500mg tablets
0501021L0BBADAH
|
Ceporex | Cefalexin | Infections | No data available |
|
Ceporex 500mg/5ml syrup
0501021L0BBAJAE
|
Ceporex | Cefalexin | Infections | No data available |
|
Cesol 150mg tablets
0505050P0BCAAAD
|
Cesol | Praziquantel | Infections | No data available |
|
Chloramphenicol 1g powder for solution for injection vials
0501070F0AAACAC
|
Chloramphenicol (Systemic) | Chloramphenicol | Infections | No data available |
|
Chloroquine phosphate 80mg/5ml oral solution
0504010F0AAAAAA
|
Chloroquine phosphate | Chloroquine phosphate | Infections | No data available |
|
Chloroquine sulfate 200mg tablets
0504010G0AAACAC
|
Chloroquine sulfate | Chloroquine sulfate | Infections | No data available |
|
Chloroquine sulfate 200mg/5ml inj ampoules
0504010G0AAAAAA
|
Chloroquine sulfate | Chloroquine sulfate | Infections | No data available |
|
Chloroquine sulfate 68mg/5ml oral solution
0504010G0AAAFAF
|
Chloroquine sulfate | Chloroquine sulfate | Infections | No data available |
|
Cidofovir 375mg/5ml solution for infusion vials
0503022C0AAAAAA
|
Cidofovir | Cidofovir | Infections | No data available |
|
Cidomycin Intrathecal 5mg/1ml inj ampoules
0501040H0BBADAH
|
Cidomycin (Systemic) | Gentamicin sulfate | Infections | No data available |
|
Cidomycin Paediatric 20mg/2ml solution for injection vials
0501040H0BBACAE
|
Cidomycin (Systemic) | Gentamicin sulfate | Infections | No data available |
|
Ciprofloxacin 100mg/50ml solution for infusion bottles
0501120L0AAABAB
|
Ciprofloxacin (Systemic) | Ciprofloxacin | Infections | No data available |
|
Ciprofloxacin 100mg/50ml solution for infusion vials
0501120L0AABQBQ
|
Ciprofloxacin (Systemic) | Ciprofloxacin | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.